- NextPlat posted fiscal 2025 net loss of USD 10 million, narrowing 54% year over year.
- Revenue fell 18% to USD 54 million.
- Gross margin shrank to about 20% from 26% a year earlier.
- Healthcare weakness drove results as pharmacy 340B contract revenue slid 61% to USD 4 million.
- Management said existing cash resources are sufficient to support planned operations for next 12 months.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-010668), on March 31, 2026, and is solely responsible for the information contained therein.
Comments